OriolaCHIX:ORIOLH 38 3-Year ROIIC % is 2.13 as of Dec. 2025. GuruFocus rates CHIX:ORIOLH with a GF Score™ of 38/100 and a GF Value™ of €1.04. The stock has 5 warning signs investors should review. Among 617 Healthcare Providers & Services companies, Oriola ranks worse than 51.7% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Oriola's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 2.13%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Oriola's 3-Year ROIIC % or its related term are showing as below:
CHIX:ORIOLh's 3-Year ROIIC % is ranked worse than 51.7% of 617
companies
in the Healthcare Providers & Services industry
Industry Median: 3.01
vs CHIX:ORIOLh: 2.13
Oriola (CHIX:ORIOLh) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Oriola 3-Year ROIIC % Related Terms
Oriola 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Oriola's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Oriola's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oriola 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Oriola's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Oriola's 3-Year ROIIC % falls into.
Oriola's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 2.5 (Dec. 2025) - 6.05259 (Dec. 2022) )
/
( 336.3 (Dec. 2025) - 503 (Dec. 2022) )
=
-3.55259
/
-166.7
=
2.13%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Oriola (CHIX:ORIOLH) has a 3-Year ROIIC % of 2.13 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Oriola and its competitors. According to the industry distribution chart, Oriola ranks #319 out of 617 companies in the Healthcare Providers & Services industry, placing it in the top 51.7%.
Is Oriola's 3-Year ROIIC % too high?
Oriola's current 3-Year ROIIC % is 2.13. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.01. Oriola's value of 2.13 is 29.2% below this industry median. Based on the distribution chart, Oriola ranks #319 out of 617 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Oriola has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Oriola's 3-Year ROIIC % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Oriola ranks #319 out of 617 companies for 3-Year ROIIC %. This places Oriola in the lower half of its industry. The industry median 3-Year ROIIC % is 3.01. Oriola's value of 2.13 is 29.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.01, based on 617 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oriola's current 3-Year ROIIC % of 2.13 is 29.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Oriola and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oriola's current 3-Year ROIIC % is 2.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oriola stock overvalued right now?
Oriola (CHIX:ORIOLH) has a current 3-Year ROIIC % of 2.13. The stock's GF Value™ is €1.04, compared to a current price of €0.94 — trading 9.8% below its estimated fair value. The current 3-Year ROIIC % is 2.13 and 29.2% below the Healthcare Providers & Services industry median of 3.01. Oriola's overall GF Score™ is 38/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Oriola (CHIX:ORIOLH), the current 3-Year ROIIC % is 2.13 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oriola (CHIX:ORIOLH) Overvalued in 2026?
Based on GuruFocus' analysis, Oriola stock appears to be undervalued.
The current stock price of €0.94 is trading 9.8% below its estimated GF Value™ of €1.04.
Key valuation signals for CHIX:ORIOLH:
3-Year ROIIC %: 2.13
GF Value™: €1.04 vs. price of €0.94 (9.8% below fair value)
Industry Position: 29.2% below the Healthcare Providers & Services median (#319 of 617)
No single metric tells the full story. See the CHIX:ORIOLH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oriola Corp is a health and wellbeing company operating in Nordic countries. It offers services such as the distribution of pharmaceuticals and other health and well-being products, services, and dose dispensing. Oriola's operations are divided into two segments which include distribution and wholesale. Geographically, the company operates in Sweden, Finland and other countries generating majority revenue from the region of Sweden.
38GF Score
Get the complete analysis for CHIX:ORIOLH
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:ORIOLH has been successfully added to your 
